SOPH (Sophia Genetics) FFO


SOPH Sophia Genetics SA SOPH
72 GF Score
Price $5.75
GF Value $5.03
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Sophia Genetics FFO?

FFO (Funds from operations) only applies to REITs.

SOPH
72GF Score
Sophia Genetics SA SOPH
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sophia Genetics (SOPH) Overvalued in 2026?

Based on GuruFocus' analysis, Sophia Genetics stock appears to be overvalued. The current stock price of $5.75 is trading 14.3% above its estimated GF Value™ of $5.03. GuruFocus considers Sophia Genetics to be Modestly Overvalued.

Key valuation signals for SOPH:

  • FFO:
  • GF Value™: $5.03 vs. price of $5.75 (14.3% above fair value)
  • GF Score™: 72/100 with 6 warning signs

No single metric tells the full story. See the SOPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sophia Genetics Business Description

Other Exchanges 90B:Germany
Address La Piece 12, Rolle, CHE, CH-1180
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
72GF Score

Get the complete analysis for SOPH

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.75
Price
$5.03
GF Value